Search
Now showing items 1-9 of 9
Lower prognostic nutritional index is associated with poorer survival in patients receiving ımmune-checkpoint ınhibitors
(Future Medicine, 2021)
Aim: Blood-based biomarkers like prognostic nutritional index (PNI) are readily available biomarkers for immunotherapy efficacy, although the data are limited. So, we aimed to evaluate the association between PNI and overall ...
Comprehensive tumor molecular profle analysis in clinical practice
(PMC, 2021)
Background: Tumor molecular profle analysis by Next Generation Sequencing technology is currently widely
applied in clinical practice and has enabled the detection of predictive biomarkers of response to targeted ...
Mesoporous bioactive glasses in cancer diagnosis and therapy: stimuli-responsive, toxicity, immunogenicity, and clinical translation
(Wiley, 2021)
Cancer is one of the top life-threatening dangers to the human survival, accounting for over 10 million deaths per year. Bioactive glasses have developed dramatically since their discovery 50 years ago, with applications ...
The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study
(Mosby Inc., 2021)
Background: Immunotherapy improves overall survival (OS) in the second and later lines of renal cell carcinoma (RCC) treatment. Recent studies have suggested that antibiotic (ATB) use either shortly before or after the ...
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database
(Future Medicine, 2021)
Aim: The authors present real-world data on the efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC). Methods: The Turkish Oncology Group Kidney Cancer Consortium (TKCC) database includes ...
Wnt/β-Catenin signaling as a driver of hepatocellular carcinoma progression: an emphasis on molecular pathways
(Dove Medical Press, 2021)
Liver cancers cause a high rate of death worldwide and hepatocellular carcinoma (HCC) is considered as the most common primary liver cancer. HCC remains a challenging disease to treat. Wnt/β-catenin signaling pathway is ...
Response to first‑line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma
(Springer Link, 2021)
Background: Atezolizumab (ATZ) has demonstrated antitumor activity in previous studies in patients with metastatic platinum-resistant urothelial carcinoma. However, the response rate of ATZ was modest. Therefore, finding ...
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab
(Springer, 2021)
Background: Atezolizumab (ATZ) has demonstrated antitumor activity and manageable safety in previous studies of patients with metastatic platinum-resistant urothelial carcinoma. However, the response rate of Atezolizumab ...
The understanding of the immunopathology in COVID-19 infection
(Taylor & Francis Online, 2021)
Coronaviruses belonging to the Coronaviridae family are single-stranded RNA viruses. The entry of SARS-CoV-2 is accomplished via ACE-2 receptors. SARS-CoV-2 infection coactivates both innate and adaptive immune responses. ...